Bank of Jackson Hole Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-475
Closed -$42.1K 479
2025
Q1
$42.1K Hold
475
0.03% 244
2024
Q4
$42.8K Buy
+475
New +$46K 0.03% 233

Other funds holding XBI

Bank of Jackson Hole Trust's XBI Position: Q2 2025 in Review

Bank of Jackson Hole Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 475 shares — an estimated $42.1K sold.

Bank of Jackson Hole Trust first reported a position in XBI in Q4 2024 and held it in 2 quarters. The position peaked at $42.8K in Q4 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Bank of Jackson Hole Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 475 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $42.1K.
  • Bank of Jackson Hole Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 2 quarters.
  • Bank of Jackson Hole Trust's State Street SPDR S&P Biotech ETF position peaked at $42.8K in Q4 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2025, filed 1 Aug 2025.